4.7 Article

SALM4 regulates angiogenic functions in endothelial cells through VEGFR2 phosphorylation at Tyr1175

Journal

FASEB JOURNAL
Volume 33, Issue 9, Pages 9842-9857

Publisher

FEDERATION AMER SOC EXP BIOL
DOI: 10.1096/fj.201802516RR

Keywords

VEGF signaling; endothelial leakage; vascular permeability; ischemia reperfusion

Funding

  1. National Research Foundation of Korea (NRF) - Ministry of Science, Information and Communications Technology, and Future Planning (MSIP) [NRF-2019R1A2C3007142]
  2. NRF - MSIP [NRF-2015M3A9B6066835]
  3. Korea Health Industry Development Institute (KHIDI) - Korean Ministry of Health and Welfare [HI16C1501]

Ask authors/readers for more resources

Angiogenesis depends on VEGF-mediated signaling. However, the regulatory mechanisms and functions of individual VEGF receptor 2 (VEGFR2) phosphorylation sites remain unclear. Here, we report that synaptic adhesion-like molecule 4 (SALM4) regulates a specific VEGFR2 phosphorylation site. SALM4 silencing in HUVECs and Salm4 knockout (KO) in lung endothelial cells (ECs) of Salm4(-/-) mice suppressed phosphorylation of VEGFR2 tyrosine (Y) 1175 (Y1173 in mice) and downstream signaling upon VEGF-A stimulation. However, VEGFR2 phosphorylation at Y951 (Y949 in mice) and Y1214 (Y1212 in mice) remained unchanged. Knockdown and KO of SALM4 inhibited VEGF-A-induced angiogenic functions of ECs. SALM4 depletion reduced endothelial leakage, sprouting, and migratory activities. Furthermore, in an ischemia and reperfusion (I/R) model, brain injury was attenuated in Salm4(-/-) mice compared with wild-type (WT) mice. In brain lysates after I/R, VEGFR2 phosphorylation at Y949, Y1173, and Y1212 were induced in WT brains, but only Y1173 phosphorylation of VEGFR2 was reduced in Salm4(-/-) brains. Taken together, our results demonstrate that SALM4 specifically regulates VEGFR2 phosphorylation at Y1175 (Y1173 in mice), thereby fine-tuning VEGF signaling in ECs.-Kim, D. Y., Park, J. A., Kim, Y., Noh, M., Park, S., Lie, E., Kim, E., Kim, Y.-M., Kwon, Y.-G. SALM4 regulates angiogenic functions in endothelial cells through VEGFR2 phosphorylation at Tyr1175.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.7
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

Article Biochemistry & Molecular Biology

MicroRNA-148a/b-3p regulates angiogenesis by targeting neuropilin-1 in endothelial cells

Hyejeong Kim, Yeongrim Ko, Hyojin Park, Haiying Zhang, Yoonjeong Jeong, Yeomyeong Kim, Minyoung Noh, Songyi Park, Young-Myeong Kim, Young-Guen Kwon

EXPERIMENTAL AND MOLECULAR MEDICINE (2019)

Article Pharmacology & Pharmacy

CU06-1004 Alleviates Experimental Colitis by Modulating Colonic Vessel Dysfunction

Ye-Seul Kim, Haiying Zhang, Sunghye Lee, Songyi Park, Minyoung Noh, Young-Myeong Kim, Young-Guen Kwon

FRONTIERS IN PHARMACOLOGY (2020)

Article Immunology

CU06-1004-Induced Vascular Normalization Improves Immunotherapy by Modulating Tumor Microenvironment via Cytotoxic T Cells

Songyi Park, Ji Hoon Oh, Dong Jin Park, Haiying Zhang, Minyoung Noh, Yeomyung Kim, Ye-Seul Kim, Hyejeong Kim, Young-Myeong Kim, Sang-Jun Ha, Young-Guen Kwon

Summary: Stabilizing tumor blood vessels and modifying the tumor microenvironment with the endothelial dysfunctional blocker CU06-1004 can synergize with anti-PD-1 immunotherapy, leading to decreased tumor growth, increased T-cell infiltration and activity, reduced hypoxia, and vessel density. These effects are significantly associated with enhanced expression of IFN gamma and PD-L1 in tumors.

FRONTIERS IN IMMUNOLOGY (2021)

Article Pharmacology & Pharmacy

Primaquine Diphosphate, a Known Antimalarial Drug, Blocks Vascular Leakage Acting Through Junction Stabilization

Minyoung Noh, Haiying Zhang, Hyejeong Kim, Songyi Park, Young-Myeong Kim, Young-Guen Kwon

Summary: Endothelial barrier integrity is crucial for vascular homeostasis, while hyperpermeability is involved in the progression of various pathological conditions. Primaquine diphosphate (PD), originally an antimalarial drug, shows potential as a blocker of vascular leakage by maintaining endothelial integrity. This effect is achieved by inhibiting VEGF-induced disruption and stabilizing cortactin actin rings through the mechanism of ubiquitin specific protease 1 (USP1) inhibition.

FRONTIERS IN PHARMACOLOGY (2021)

Article Biochemistry & Molecular Biology

CU06-1004 enhances vascular integrity and improves cardiac remodeling by suppressing edema and inflammation in myocardial ischemia-reperfusion injury

Haiying Zhang, Hyeok Kim, Bong Woo Park, Minyoung Noh, Yeomyeong Kim, Jeongeun Park, Jae-Hyun Park, Jin-Ju Kim, Woo-Sup Sim, Kiwon Ban, Hun-Jun Park, Young-Guen Kwon

Summary: The drug CU06-1004 has shown potential in improving cardiac function by inhibiting CMEC hyperpermeability and reducing inflammation and infiltration in infarcted hearts. It enhances vascular integrity, reduces tissue damage, and provides a promising therapeutic option for preventing lethal myocardial I/R injury.

EXPERIMENTAL AND MOLECULAR MEDICINE (2022)

Article Plant Sciences

Extract of Moutan radicis cortex and Cinnamomi ramulus ameliorates laser-induced choroidal neovascularization in Brown-Norway rats

Ik Soo Lee, Chan-Sik Kim, Junghyun Kim, Kyuhyung Jo, Soo Wang Hyun, Haiying Zhang, MinYoung Noh, Young-Guen Kwon, MyungHwa Kim, Jin Sook Kim

Summary: The combined extract of Moutan radicis cortex and Cinnamomi ramulus showed inhibitory effect against laser-induced pathological CNV by reducing lesion areas and fluorescein leakage. The extract and its constituents also decreased cell migration, tube formation, and hyper permeability while inhibiting phosphorylation of FAK and p38 MAPK, suggesting potential therapeutic strategies for wet AMD patients.

PHYTOMEDICINE (2022)

Article Pharmacology & Pharmacy

Oral administration of CU06-1004 attenuates vascular permeability and stabilizes neovascularization in retinal vascular diseases

Minyoung Noh, Yeomyeong Kim, Haiying Zhang, Hyejeong Kim, Cho-Rong Bae, Sunghye Lee, Young-Guen Kwon

Summary: Retinal vascular diseases are a major cause of blindness worldwide, with common mechanisms including VEGF signaling, hypoxia, and inflammation. Current treatments improve outcomes but have limitations and side effects. A new therapeutic approach, such as oral administration of CU06-1004, could potentially address the underlying cause and provide better treatment for retinal vascular diseases.

EUROPEAN JOURNAL OF PHARMACOLOGY (2023)

Article Allergy

CU06-1004 alleviates vascular hyperpermeability in a murine model of hereditary angioedema by protecting the endothelium

Sunghye Lee, Yeomyeong Kim, Ye-Seul Kim, Haiying Zhang, Minyoung Noh, Young-Guen Kwon

Summary: In this study, CU06-1004 was found to alleviate vascular hyperpermeability caused by BK by protecting endothelial barrier function. The results suggest that CU06-1004 could serve as a potential prophylactic/therapeutic approach for HAE.

ALLERGY (2023)

No Data Available